What does PJ NAERT MEDICALS do?

PJ NAERT MEDICALS is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 30 March 2011, 1 establishment.

What is the address of PJ NAERT MEDICALS?

The registered office of PJ NAERT MEDICALS is located at Kerkeweg 7, 8490 Jabbeke.

Is PJ NAERT MEDICALS still active?

Yes. According to the CBE (31 October 2026) PJ NAERT MEDICALS is active, legal situation “Normale toestand”, started on 30 March 2011.

Is PJ NAERT MEDICALS registered on Peppol?

Yes, PJ NAERT MEDICALS is registered on the Peppol network with ID 0208:0835053501.

What is the enterprise number of PJ NAERT MEDICALS?

The enterprise number of PJ NAERT MEDICALS is BE0835053501.

When was PJ NAERT MEDICALS founded?

PJ NAERT MEDICALS was founded on 30 March 2011.

Who are the directors of PJ NAERT MEDICALS?

According to the 2026 annual accounts, the directors of PJ NAERT MEDICALS are: PETER-JAN NAERT, EVELIEN VERRUE.

Is PJ NAERT MEDICALS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 March 2011; 5 annual accounts filed, latest fiscal year 2026; 2 directors known from the annual account.

How much profit did PJ NAERT MEDICALS make in 2026?

PJ NAERT MEDICALS recorded a loss after taxes of € 6,712 in financial year 2026.

What is the revenue of PJ NAERT MEDICALS?

As a small company, PJ NAERT MEDICALS is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 9,039.

How many employees does PJ NAERT MEDICALS have?

According to the 2026 annual accounts, PJ NAERT MEDICALS has 0 full-time equivalents (FTE).

PJ NAERT MEDICALS (Private Limited) - Jabbeke

Dossier PJ NAERT MEDICALS, printed on 31 October 2026 from databakkes.be/en/0835053501/pj-naert-medicals. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 39 % of short-term debt in 2026; threshold 65 %.

Financials

Financial year 2026

PJ NAERT MEDICALS from Jabbeke, company number BE0835053501, closed financial year 2026 with a result of € -6,712 after tax. For that financial year PJ NAERT MEDICALS recorded a gross margin of € 9,039 and equity of € 144,398. Compared with financial year 2025, the result moved from € 5,618 to € -6,712. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 14, 2026.

What it is worth Healthy

€ 144,398

▼ 4% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -6,712

▼ still € 5,618 profit in 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 16,975

▲ € 15,764 vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 131,998.

People and assets in 2026

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 8,669

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 139,463

▲ 35% vs 2025

€ 40,960 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 7,447

▲ € 6,027 vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,635

▼ 16% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 138,380 Gross margin 2023: € 138,380 First fiscal year in the series	€ 77,795 Gross margin 2024: € 77,795 ▼ 44% vs 2023 (€ 138,380) Unfavourable step	€ 26,209 Gross margin 2025: € 26,209 ▼ 66% vs 2024 (€ 77,795) Unfavourable step	€ 9,039 Gross margin 2026: € 9,039 ▼ 66% vs 2025 (€ 26,209) Unfavourable step	▼ 66%
Profit after taxes	€ 111,190 Profit after taxes 2023: € 111,190 First fiscal year in the series	€ 33,544 Profit after taxes 2024: € 33,544 ▼ 70% vs 2023 (€ 111,190) Unfavourable step	€ 5,618 Profit after taxes 2025: € 5,618 ▼ 83% vs 2024 (€ 33,544) Unfavourable step	€ -6,712 Profit after taxes 2026: € -6,712 ▼ € 12,331 vs 2025 (€ 5,618) Unfavourable step	▼ € 12,331
Equity	€ 111,948 Equity 2023: € 111,948 First fiscal year in the series	€ 145,492 Equity 2024: € 145,492 ▲ 30% vs 2023 (€ 111,948) Favourable step	€ 151,110 Equity 2025: € 151,110 ▲ 4% vs 2024 (€ 145,492) Favourable step	€ 144,398 Equity 2026: € 144,398 ▼ 4% vs 2025 (€ 151,110) Unfavourable step	▼ 4%
Total debts	€ 446,108 Total debts 2023: € 446,108 First fiscal year in the series	€ 399,201 Total debts 2024: € 399,201 ▼ 11% vs 2023 (€ 446,108) Favourable step	€ 133,568 Total debts 2025: € 133,568 ▼ 67% vs 2024 (€ 399,201) Favourable step	€ 213,015 Total debts 2026: € 213,015 ▲ 59% vs 2025 (€ 133,568) Unfavourable step	▲ 59%
Cash	€ 4,167 Cash 2023: € 4,167 First fiscal year in the series	€ 16,116 Cash 2024: € 16,116 ▲ 287% vs 2023 (€ 4,167) Favourable step	€ 1,211 Cash 2025: € 1,211 ▼ 92% vs 2024 (€ 16,116) Unfavourable step	€ 16,975 Cash 2026: € 16,975 ▲ € 15,764 vs 2025 (€ 1,211) Favourable step	▲ € 15,764
Land & buildings	€ 295,680 Land & buildings 2023: € 295,680 First fiscal year in the series	€ 276,470 Land & buildings 2024: € 276,470 ▼ 6% vs 2023 (€ 295,680) Unchanged	€ 0 Land & buildings 2025: € 0 ▼ 100% vs 2024 (€ 276,470) Unchanged	-
Retained profit	€ 99,548 Retained profit 2023: € 99,548 First fiscal year in the series	€ 133,092 Retained profit 2024: € 133,092 ▲ 34% vs 2023 (€ 99,548) Favourable step	€ 138,710 Retained profit 2025: € 138,710 ▲ 4% vs 2024 (€ 133,092) Favourable step	€ 131,998 Retained profit 2026: € 131,998 ▼ 5% vs 2025 (€ 138,710) Unfavourable step	▼ 5%
Dividend	€ 85,000 Dividend 2023: € 85,000 First fiscal year in the series	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 85,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2026: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 271,484 Bank debt 2023: € 271,484 First fiscal year in the series	€ 338,427 Bank debt 2024: € 338,427 ▲ 25% vs 2023 (€ 271,484) Unfavourable step	€ 103,084 Bank debt 2025: € 103,084 ▼ 70% vs 2024 (€ 338,427) Favourable step	€ 139,463 Bank debt 2026: € 139,463 ▲ 35% vs 2025 (€ 103,084) Unfavourable step	▲ 35%
Balance sheet total	€ 558,056 Balance sheet total 2023: € 558,056 First fiscal year in the series	€ 544,693 Balance sheet total 2024: € 544,693 ▼ 2% vs 2023 (€ 558,056) Unchanged	€ 284,679 Balance sheet total 2025: € 284,679 ▼ 48% vs 2024 (€ 544,693) Unchanged	€ 357,413 Balance sheet total 2026: € 357,413 ▲ 26% vs 2025 (€ 284,679) Unchanged	▲ 26%

Key figures of PJ NAERT MEDICALS, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to PJ NAERT MEDICALS?

What happened at PJ NAERT MEDICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 14, 2026 New annual accounts for financial year 2026: loss of € 6,712 (▼ € 12,331 vs 2025). Source: NBB ↗
2015 EVELIEN VERRUE became a director. NBB
Apr 18, 2011 New establishment in Jabbeke. KBO
Mar 30, 2011 Start of the company according to the CBE. KBO
2011 PETER-JAN NAERT became a director. NBB

In short

From € 111,190 profit in 2023 to € 6,712 loss in 2026.

Paid € 35,904 in corporate taxes since 2023.

Best year ever: 2023, with € 111,190 profit.

Paid out € 85,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

PETER-JAN NAERT

EVELIEN VERRUE

PJ NAERT MEDICALS

Patella 100%

Behind PJ NAERT MEDICALS are PETER-JAN NAERT and EVELIEN VERRUE. It owns 100% of Patella itself.

Directors

According to the 2026 annual accounts

PETER-JAN NAERT

Director

since 2011

EVELIEN VERRUE

Director

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkeweg 7

8490 Jabbeke

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

PATELLA same network

€ 176,041 gross margin · 2025

VENA

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0835.053.501

VAT number

BE 0835.053.501

Registered office

Kerkeweg 7, 8490 Jabbeke

Names & denominations

PJ NAERT MEDICALS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 March 2011

Peppol

Active · Active since 27 Mar 2026

Activities · NACE

Activiteiten van holdings

Holdings

Activiteiten van reclamebureaus

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Groothandel in farmaceutische en medische artikelen

Activiteiten van hoofdkantoren

View on CBE Public ↗ Annual accounts (NBB) ↗

PJ NAERT MEDICALS

Warning lights

Financials

What happened to PJ NAERT MEDICALS?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions